BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 11106695)

  • 1. Re: effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin.
    Archer DF; Bush T; Nachtigall LE
    J Natl Cancer Inst; 2000 Dec; 92(23):1950-2. PubMed ID: 11106695
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin.
    Kuller LH
    J Natl Cancer Inst; 2000 Jul; 92(13):1100-1. PubMed ID: 10880556
    [No Abstract]   [Full Text] [Related]  

  • 3. More about: effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin.
    Magnusson C; Persson I; Adami HO
    J Natl Cancer Inst; 2000 Jul; 92(14):1183-4. PubMed ID: 10904095
    [No Abstract]   [Full Text] [Related]  

  • 4. Estrogen-progestin increases breast cancer risk.
    Stephens MB
    J Fam Pract; 2000 Apr; 49(4):301-2. PubMed ID: 10778832
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of estrogen plus progestin hormone therapy on breast cancer mortality: still unresolved.
    Schairer C; Brinton LA
    J Natl Cancer Inst; 2013 Apr; 105(8):513-4. PubMed ID: 23543780
    [No Abstract]   [Full Text] [Related]  

  • 6. Breast cancer and hormone-replacement therapy: the Million Women Study.
    Garton M
    Lancet; 2003 Oct; 362(9392):1328; author reply 1330-1. PubMed ID: 14575985
    [No Abstract]   [Full Text] [Related]  

  • 7. Re: Estrogen plus progestin and breast cancer incidence and mortality in the women's health initiative observational study.
    Shapiro S; deVilliers TJ; Pines A; Sturdee DW; Archer DF; Baber RJ; Panay N; Farmer RD; Stevenson JC; Mueck AO; Burger HG; Gompel A
    J Natl Cancer Inst; 2014 Feb; 106(2):djt372. PubMed ID: 24363446
    [No Abstract]   [Full Text] [Related]  

  • 8. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.
    Colditz GA; Hankinson SE; Hunter DJ; Willett WC; Manson JE; Stampfer MJ; Hennekens C; Rosner B; Speizer FE
    N Engl J Med; 1995 Jun; 332(24):1589-93. PubMed ID: 7753136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Menopausal estrogen and estrogen-progestin replacement therapy and risk of breast cancer (United States).
    Schairer C; Byrne C; Keyl PM; Brinton LA; Sturgeon SR; Hoover RN
    Cancer Causes Control; 1994 Nov; 5(6):491-500. PubMed ID: 7827235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen-progestin replacement therapy and endometrial cancer.
    Pike MC; Peters RK; Cozen W; Probst-Hensch NM; Felix JC; Wan PC; Mack TM
    J Natl Cancer Inst; 1997 Aug; 89(15):1110-6. PubMed ID: 9262248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormone replacement therapy and breast cancer.
    Stanford JL; Weiss NS
    Arch Fam Med; 1996 Jun; 5(6):349-50. PubMed ID: 8640325
    [No Abstract]   [Full Text] [Related]  

  • 12. Estrogen, estrogen plus progestin therapy, and risk of breast cancer.
    Colditz GA
    Clin Cancer Res; 2005 Jan; 11(2 Pt 2):909s-17s. PubMed ID: 15701886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Postmenopausal hormone therapy--an update. Benefit versus risk--important to identify women with increased breast cancer risk].
    von Schoultz B
    Lakartidningen; 2009 Aug 19-25; 106(34):2041-2. PubMed ID: 19769143
    [No Abstract]   [Full Text] [Related]  

  • 14. Postmenopausal hormone therapy and the risk of breast cancer: a contrary thought.
    Speroff L
    Menopause; 2008; 15(2):393-400. PubMed ID: 17925662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women.
    Stanford JL; Weiss NS; Voigt LF; Daling JR; Habel LA; Rossing MA
    JAMA; 1995 Jul; 274(2):137-42. PubMed ID: 7596001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of breast cancer with HRT depends on therapy type and duration.
    Saul H; Gursul D; Cassidy S; Vinogradova Y
    BMJ; 2022 Mar; 376():o485. PubMed ID: 35260385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re: Breast cancer risk in relation to the interval between menopause and starting hormone therapy.
    Grant EC
    J Natl Cancer Inst; 2011 Jul; 103(13):1069; reply 1069-70. PubMed ID: 21700925
    [No Abstract]   [Full Text] [Related]  

  • 18. Cancer risk in women receiving estrogen-progestin replacement therapy.
    Persson I
    Maturitas; 1996 May; 23 Suppl():S37-45. PubMed ID: 8865138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk.
    Schairer C; Lubin J; Troisi R; Sturgeon S; Brinton L; Hoover R
    JAMA; 2000 Jan; 283(4):485-91. PubMed ID: 10659874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changing concepts: Menopausal hormone therapy and breast cancer.
    Chlebowski RT; Anderson GL
    J Natl Cancer Inst; 2012 Apr; 104(7):517-27. PubMed ID: 22427684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.